Relationship between FT3 and cardiovascular disease in non-dialytic patients with chronic kidney disease

Hong-xiu DU,Zhao-hui NI,Bei-li SHI,Zan-zhe YU,Le-yi GU,Qin WANG,Shan MOU,Li-ou CAO,Wen-yan ZHOU
DOI: https://doi.org/10.3969/j.issn.1671-2870.2007.06.013
2007-01-01
Abstract:Objective To investigate the changes of serum thyroid hormones in non-dialytic patients with chronic kidney disease(CKD),and to clarify the relationship between thyroid hormones and cardiovascular disease(CVD)in the patients.Methods A hundred ninty-five non-dialytic patients with CKD and 10 controls with both normal urine routine and microalbuminuria were enrolled.The serum levels of FT3,FT4,T3,T4 and TSH in all the patients were detected by the RIA method.Relationship between levels of the thyroid hormones and results of carotid ultrasonography,characteristics of Doppler coluor echocardiogram,and history of CVD was analyzed.Results Compared to the control group,mean serum FT3 levels were significantly decreased in CKD groups(4.02±0.78)nmol/L vs(4.62±0.59)nmol/L,P<0.05.The serum levels of FT3 were lower in non-dialytic CKD patients with congestive heart failure or artherosclerosis cardiovascular diseases than that in those without the heart diseases(3.68±0.14)nmol/L vs(4.13±0.06)nmol/L and(3.83±0.10)nmol/L vs(4.17±0.07)nmol/L,both P<0.05.Serum FT3 level was negatively correlated with left ventricular mass index(LVMI)(r=-0.326,P<0.001)and inner diameter of common carotid artery(r=-0.428,P<0.001).Multiple regression analysis showed that serum FT3 level was the individual risk factor of LVMI(β=-0.200,P=0.008)and inner diameter of common carotid artery(β=-0.184,P=0.023)in CKD patients.Conclusions The serum levels of FT3 are lower in patients with non-dialytic CKD.The serum FT3 level is significantly associated with CVD and is useful in evaluation of the patients with CKD.
What problem does this paper attempt to address?